DOCSLIB.ORG

Global Illicit Drug Trends 2003 Explanatory Notes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Global Illicit Drug Trends 2003 Explanatory Notes T S 3 I D 0 C N 0 I E L 2 L R I T L G A U B R O L D G G L O B A L I L L I C I T D R U G T R E N D S 2 0 0 3 ISSN 1020-9298 Sales No. E.03.XI.5 ISBN 92-1-148156-2 United Nations publication Printed in Austria Printed in 2003–3,730 V.03-84614–June Vienna International Centre, P.O. Box 500, A-1400 Vienna, Austria A-1400 Vienna, Box 500, International Centre, P.O. Vienna (+43 1) 26060-0, Fax: (+43 1) 26060-5866, www.unodc.org Tel: coverpage_final.qxd 29/05/2003 15:08 Page 1 Acknowledgements The following individuals in the Research Section of UNODC contributed to the preparation of the present book: Sandeep Chawla Thibault le Pichon Thomas Pietschmann Patrick Seramy Aruna Nathwani Johny Thomas Ali Saadedin The preparation of the report would not have been possible without the contribution of drug control authorities in many countries, as well as several UNODC staff, sections and field offices. The report, which grew out of the original concep- tion of Thibault le Pichon and Patrick Seramy, has been an annual publication since 1999. OFFICE ON DRUGS AND CRIME Vienna G L O B A L I L L I C I T D R U G T R E N D S 2 0 0 3 UNITED NATIONS New York, 2003 The Office for Drug Control and Crime Prevention (UNODCCP) became the Office on Drugs and Crime (UNODC) on 1 October 2002. The Office on Drugs and Crime includes the United Nations International Drug Control Programme (UNDCP). United Nations Publication Sales No. E.03.XI.5 ISBN 92-1-148156-2 The boundaries, names and designations used in all maps in this book do not imply official endorsement or acceptance by the United Nations. This publication has not been formally edited. PREFACE At the twentieth special session of the General Assembly in 1998, States Members agreed to make significant progress towards the control of supply and demand for illicit drugs by the year 2008. They noted that this objective could only be achieved by means of the 'balanced approach' (giving demand as much attention as supply), and on the basis of regular assess- ments of the drug problem. The aim of the present report is to contribute to such assessments by presenting supply and demand statistics and analysis on the evolution of the global illicit drug problem. Reliable and systematic data to assess the drug problem, and to monitor progress in achiev- ing the goals set by the General Assembly, however, is not readily available. The present report is based on data obtained primarily from the annual reports questionnaire (ARQ) sent by Governments to the United Nations Office on Drugs and Crime (UNODC) in 2002, supplement- ed by other sources. Two of the main data limitations are that: (a) these annual questionnaires are not systematic enough, both in terms of the number of countries responding and of con- tent; and (b) most countries lack the monitoring systems required to produce reliable, compre- hensive and internationally comparable data. There have been some recent improvements. National illicit coca and opium monitoring systems, supported by UNODC, are now providing annual cultivation estimates for the main producing countries. However, data on other links in the drug chain, particularly on the demand side, are progressively weaker. This report tries to overcome the data limitations by presenting, annually, estimates and analy- sis of illicit drug production, trafficking and consumption. The first section deals with Trends in illicit drug production, trafficking and consumption. The second section provides the Statistics on which the globally aggregated estimates and trends are based. The difficulties of measuring an illicit activity are well known. Although they impose obvious lim- itations on data, it is possible to make reasonable order-of-magnitude estimates. It is also high- ly desirable to do so, because such estimates encourage transparency, stimulate discussion and build knowledge. Empirical evidence is the only realistic basis for policy-making. This report, by presenting what we know, and by showing what we do not know, contributes to build- ing the knowledge base for better policy. It also sets the basis for more focussed action to achieve the goals set in 1998 and reiterated at the Ministerial segment of the UN Commission on Narcotic Drugs in April 2003. Antonio Maria Costa Executive Director United Nations Office on Drugs and Crime 1 Global Illicit Drug Trends 2003 Explanatory notes EXPLANATORY NOTE This report has been reproduced without formal editing. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The names of territories and administrative areas are in italics. The following abbreviations have been used in this report: ARQ annual reports questionnaire ATS amphetamine-type stimulants CICAD Inter-American Drug Abuse Control Commission CIS Commonwealth of Independent States DEA United States of America, Drug Enforcement Administration DMT N,N - dimethyltryptamine DOB brolamfetamine EMCDDA European Monitoring Centre for Drugs and Drug Addiction ESPAD European School Survey Project on Alcohol and other Drugs F.O. UNODC Field Office ICMP UNODC Global Illicit Crop Monitoring Programme IDU Injecting drug use INCB International Narcotics Control Board INCSR United States of America, International Narcotics Control Strategy Report Interpol/ICPO International Criminal Police Organization LSD lysergic acid diethylamide NAPOL National Police ODCCP United Nations Office for Drug Control and Crime Prevention PCP phencyclidine UNAIDS Joint and Co-sponsored United Nations Programme on Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome UNDCP United Nations International Drug Control Programme UNODC United Nations Office on Drugs and Crime WCO World Customs Organization WHO World Health Organization Govt. Government u. Unit lt. Litre kg Kilogram ha Hectare mt Metric ton 3 Global Illicit Drug Trends 2003 Table of contents TABLE OF CONTENTS EXECUTIVE SUMMARY.................................................................................................................... 7 1. TRENDS 1.1. Production 1.1.1. Overview ......................................................................................................... 15 1.1.2. Opium / Heroin ................................................................................................ 15 1.1.3. Coca / Cocaine................................................................................................ 22 1.1.4. Cannabis ......................................................................................................... 29 1.1.5. Amphetamine-type stimulants......................................................................... 31 1.2. Trafficking 1.2.1. Overview ......................................................................................................... 47 1.2.2. Opium / Heroin ................................................................................................ 52 1.2.3. Coca / Cocaine................................................................................................ 63 1.2.4. Cannabis ......................................................................................................... 71 1.2.5. Amphetamine-type stimulants......................................................................... 82 1.3. Consumption 1.3.1. Overview ....................................................................................................... 101 1.3.2. Opium / Heroin .............................................................................................. 107 1.3.3. Coca / Cocaine.............................................................................................. 129 1.3.4. Cannabis ....................................................................................................... 136 1.3.5. Amphetamine-type stimulants....................................................................... 141 2. STATISTICS 2.1. Production 2.1.1. Opium / Heroin................................................................................................. 165 2.1.1.1. Afghanistan............................................................................................ 166 2.1.1.2. Pakistan................................................................................................. 177 2.1.1.3. Myanmar................................................................................................ 179 2.1.1.4. Lao PDR................................................................................................ 184 2.1.1.5. Reported eradication of opium poppy ................................................... 187 2.1.1.6. Seizure of illicit laboratories................................................................... 188 2.1.2. Coca / Cocaine ............................................................................................... 190 2.1.2.1. Colombia ............................................................................................... 191 2.1.2.2. Peru ....................................................................................................... 197 2.1.2.3. Bolivia .................................................................................................... 200 2.1.2.4. Reported eradication of coca ...............................................................
Load more

Recommended publications
  • 1. CAMBODIA 1.1 General Situation 1.1.1 Drug Use There Are No
    COUNCIL OF Brussels, 15 April 2014 THE EUROPEAN UNION (OR. en) 8990/14 CORDROGUE 26 ASIE 22 NOTE From: Japanese Regional Chair of the Dublin Group To: Dublin Group No. prev. doc.: 14715/13 Subject: Regional Report on South East Asia and China 1. CAMBODIA 1.1 General situation 1.1.1 Drug use There are no consistent statistics as to the exact number of people who use drugs in Cambodia. However the general consensus among the Royal Government of Cambodia and international agencies is that there are currently between 12,000 and 28,000 people who use drugs. Methamphetamine pills are the most widely used drug in Cambodia, although crystalline methamphetamine is becoming more widely available, with use on the rise, particularly in Phnom Penh and among unemployed youth. Whereas illicit drug use was previously concentrated primarily in urban settings, in recent years it has been expanding into rural areas, in particular in the provinces adjacent to Lao PDR and Thailand (INCSR Cambodia 2012). Drug use among women and within prisons appears to be on the rise (UNODC 2013). 8990/14 JV/fm 1 DG D 2C EN Table 1. Rank of primary drugs of concern in Cambodia, 2008-2012 Drug type 2008 2009 2010** 2011*** 2012**** Methamphetamine pills ● 2* 1 2 2 Crystalline methamphetamine ● 1* 2 1 1 Ecstasy ● ● ● 6 ● Cannabis ● ● 4 4 4 Heroin ● ● 3 5 ● Inhalants ● ● ● 3 3 Opium ● ● ● ● ● ● = Not reported Source(s): *NACD 2010a. **2010 rankings based on DAINAP data and Cambodia country reports. ***NACD 2012b. ****2012 rankings are based on data provided by the National Authority for Combating Drugs.
    [Show full text]
  • Sanofi-Synthelabo Annual Report 2001
    annual report Contents Group profile page 1 Chaiman’s message page 3 Key figures page 6 Stock exchange information page 8 Corporate governance page 11 Management Committee page 12 Prioritizing R&D and growth so as to drive back disease Research and development page 16 Medicine portfolio page 22 International organization page 36 2001 Annual report 2001 Annual report Working for the long term, a company - which respects people and their environment Ethics page 46 page 50 Sanofi-Synthélabo Human resources policy Health Safety Environment policy page 54 This annual report was designed and produced by: The Sanofi-Synthélabo Corporate Communications and Finance Departments and the Harrison&Wolf Agency. Photo credits: Getty Images / Barry Rosenthal • Getty Images / Steve Rowell • INSERM / J.T. Vilquin • CNRS / F. Livolant • Photothèque Sanofi-Synthélabo • Photothèque Sanofi-Synthélabo Recherche Montpellier • Publicis Conseil / Adollo Fiori • Luc Benevello • Olivier Culmann • Michel Fainsilber • Vincent Godeau • Florent de La Tullaye • Patrick Lefevre • Gilles Leimdorfer • Martial Lorcet • Fleur Martin Laprade • Patrice Maurein • Bernadette Müller • Laurent Ortal • Harutiun Poladian Neto • Anne-Marie Réjior • Marie Simonnot • Denys Turrier • The photographs which illustrate this document feature Sanofi-Synthélabo employees: we would like to thank them for their contribution. 395 030 844 R.C.S. Paris Group Profile 2nd pharmaceutical group in France 7th pharmaceutical group in Europe One of the world’s top 20 pharmaceutical groups Four areas of specialization Sanofi-Synthélabo has a core group of four therapeutic areas: • Cardiovascular / thrombosis • Central nervous system • Internal medicine • Oncology This targeted specialization enables the group to be a significant player 2001 Annual report 2001 Annual report in each of these areas.
    [Show full text]
  • Methamphetamine Use: Lessons Learned
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Methamphetamine Use: Lessons Learned Author(s): Dana Hunt, Ph.D.; Sarah Kuck; Linda Truitt, Ph.D. Document No.: 209730 Date Received: February 2006 Award Number: 99-C-008 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. ANALYTIC SUPPORT PROGRAM CONTRACT TASK REQUIREMENT T-043: Methamphetamine Use: Lessons Learned Contract No. 99-C-008 Cambridge, MA Lexington, MA Hadley, MA Bethesda, MD Chicago, IL January 31, 2006 Prepared for Raymond C. German Contracting Officer Christine Crossland Senior Social Science Analyst National Institute of Justice Office of Justice Programs Acquisition Management Division 810 Seventh Street, SW Washington, D.C. 20001 Prepared by Dana Hunt, Ph.D. Sarah Kuck Abt Associates Inc. Linda Truitt, Ph.D. 55 Wheeler Street Cambridge, MA 02138 Contents Executive Summary...............................................................................................................iii History of Methamphetamine Use .................................................................................iii Trends.............................................................................................................................iii
    [Show full text]
  • National Drug Threat Assessment 2002
    National Drug Intelligence Center U.S. Department of Justice U.S. Department of Justice National Drug Intelligence Center Product No. 2002-Q0317-001 December 2001 National Drug Threat Assessment 2002 National Drug Intelligence Center 319 Washington Street, 5th Floor Johnstown, PA 15901-1622 (814) 532-4601 National Drug Threat Assessment 2002 From the Director: I am pleased to present the National Drug Threat Assessment 2002, the culmination of dedicated work by the National Drug Intelligence Center in partnership with federal, state, and local agencies and organizations. In accordance with the provisions of the General Counterdrug Intelligence Plan, the National Drug Threat Assessment integrates foreign and domestic counterdrug intelligence and information on domestic drug consumption trends in a single report. This report is a comprehensive assessment of the threat posed to our society by illicit drugs. It integrates the most recently available reporting from national-level law enforcement, intelligence, and health and human service agencies including the Drug Enforcement Administration, Federal Bureau of Investigation, U.S. Coast Guard, U.S. Customs Service, El Paso Intelligence Center, Financial Crimes Enforcement Network, Crime and Narcotics Center, National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, and National Institute of Justice. It incorporates data from current national drug abuse indicators—Arrestee Drug Abuse Monitoring Program, Drug Abuse Warning Network, Monitoring the Future Study, National Household Survey on Drug Abuse, Parents’ Resource Institute on Drug Education Survey, and Treatment Episode Data Set—to accurately and reliably depict the current domestic drug abuse situation. The National Drug Threat Assessment draws on information provided by nearly 2,600 state and local law enforcement agencies throughout the country to document the current threat and emerging trends in drug trafficking and related criminal activity in the United States.
    [Show full text]
  • Societal Risk Perception by Laypersons Living in Venezuela
    Societal risk perception by laypersons living in Venezuela. A Latin countries comparison* La percepción de riesgo social por laicos que viven en Venezuela. Una comparación entre países Latinos Received: 23 July 2015 | Accepted: 01 December 2015 Ana Gabriela Guédez** Universidad de Jean Jaurès, Francia ABSTRACT The present study presents the mean risk magnitude judgments on 91 activities, substances, and technologies expressed by Venezuelan adults living in the two main cities of this country: Caracas and Maracaibo. These judgments were compared methodically with findings on other samples of previous studies, namely four other Latin countries: France, Spain, Brazil, and Portugal. The aim of this study was to structure the cross-country differences in risk perception between the aforementioned countries and Venezuela using cluster analysis. A 91-hazard x 5 country matrix was created. Two main clusters were found. The Economically and Socially Challenging group (Venezuela and Portugal) and the Western Europe group (France and Spain). Brazil was situated closer to the **Departamento de Psicología Cognitiva. E-mail: Venezuelan and Portugal cluster than was the Western Europe group. [email protected] The common denominator in the Economically and Socially Challenging group can be the economic and social problems that both of these countries struggle against. It was reasonable that Brazil was closer to this cluster, given its similarities to both countries (in geographical and cultural terms). More explanations for these clusters were presented in the discussion. Finally, some recommendations and limitations are also presented and more research in this field is suggested as well. Keywords risk perception, social psychology, latin countries, Venezuela.
    [Show full text]
  • (ATS) Production and Trafficking in Southeast Asia Countries
    Risalah HUKUM Fakultas Hukum Unmul, Juni 2010, Hal. 53 - 62 Vol. 6, No. 1 ISSN 021-969X Amphetamines Type Stimulant (ATS) Production and Trafficking In Southeast Asia Countries Milda Istiqomah Fakultas Hukum Universitas Brawijaya Jl.MT.Haryono Nomor 169 Malang 65145 e-mail:[email protected] ABSTRACT This article addresses the pattern of Amphetamines Type Stimulants (ATS) production and trafficking in Southeast Asia countries. The objective of this article is to investigate organizational form and trafficking network of ATS within the region. Indonesia, Myanmar, and Cambodia will be used as analyzing case of the largest amphetamine producing and trafficking centre in the territory. The poverty, geo-strategic location, unstable sociopolitical situation and systemic corruption in law enforcement agencies are identified as the root of the emergence of multifaceted and transnational drugs trafficking in Southeast Asia. This article also provides suggestion on how to circumvent the impediments faced by the governments. Key words: amphetamines type stimulants and trafficking Introduction countries are responsible for contributing the Southeast Asia countries are facing a illicit drugs trafficking within the world. Several serious threat of their security from drugs countries within this region are posing as trafficking recently. The golden triangle producing, supplying and transiting point of countries consisting of Burma, Thailand and illicit drugs. Laos are pointed as the world’s second largest Gary Reid et al address a report of opium producer and supplier in the Asia Pacific drug production, trafficking and trade in Asia region. Amphetamines productions are also and Pacific Island countries. 1 They estimate found throughout most of the Southeast Asia that Myanmar is the largest producer of opium region, in particular Indonesia, Myanmar and around “370 metric tones” in the Asia region, Cambodia.
    [Show full text]
  • The Health Dimension of Climate Change
    The Health Dimension of Climate Change Public Disclosure Authorized THE WORLD BANK GROUP 1818 H Street, N.W. WASHINGTON, D.C. 20433 Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized 1 ACKNOWLEDGEMENTS TABLE OF ACRONYMS 2 TABLE OF CONTENTS CONTEXT I. The Health Dimension of Climate Change II. Analytical time scales III. Types of Impacts IV. Extremes and Averages V. Cross-cutting Issues VI. Timeframe for Action VII. Assessment Frameworks VIII. Adaptive Capacity in Health Systems IX. Report Structure SECTION ONE Evidence Base for Climate Change Events and Health Impacts in ECA 1.1 Overview 1.2 Extreme Weather Events 1.2.1 Floods Flood-related mortality in ECA Water-borne and food-borne diseases Vector-borne diseases Rodent-borne disease Others 1.2.2 Heat waves Excess mortality Cause-specific mortality Heat -related morbidity Additional Risk Factors 1.2.3 Droughts 1.3 Changing Average Temperatures & Impacts on Health in ECA Vector-borne diseases Water-borne and food-borne diseases Allergies 1.4. Other Impacts of Climate Change: Migration The Impact of Migration on Health 3 SECTION TWO Country-Level Climate Change-Health Vulnerability Assessment 2.1 Overview 2.2 Toolkit proposal, definitions and rationale for indicators 2.3 Climate Change-Health Vulnerability Assessment Toolkit SECTION THREE Climate Change-Health Adaptive Strategies 3.1 Overview 3.2 Adaptive Strategies for Extreme Weather Events (table) 3.3 Adaptive Strategies for Changing Averages (table) 3.4 Adaptive Strategies for Migration-Related Health
    [Show full text]
  • Monetary Union, Price Level Convergence, and Inflation: How Close Is Europe to the United States?
    Monetary union, price level convergence, and inflation: How close is Europe to the United States? John H. Rogers* July 2000 (Current Draft: January 11, 2003) Abstract: I document the pattern of price dispersion across European and U.S. cities from 1990 to 2001. I find a striking decline in dispersion for traded goods prices in Europe, most of which took place between 1991 and 1994. The level of traded goods price dispersion in the euro area is now quite close to that of the United States. I examine several possible explanations for the decline in Europe: harmonization of tax rates, convergence of incomes and labor costs, liberalization of trade and factor markets, and increased coherence of monetary policy. Surprisingly, there is only weak correlation between changes in the dispersion of traded goods prices and nominal exchange rates. I also investigate the determinants of national inflation rates in Europe. Although some is explained by price level convergence, conventional factors are more important. There is no evidence of a Balassa-Samuelson effect on inflation. Finally, after showing that prices in likely next-round entrants into the euro zone are well below prices in Western Europe, I discuss the potential inflationary consequences of accession into monetary union for Eastern Europe. JEL classification: E31, F36, F41 Keywords: economic integration, prices, exchange rates, euro * Senior economist, International Finance Division, Board of Governors of the Federal Reserve System, Washington, D.C. 20551. 202-452-2873, [email protected]. I am grateful to seminar participants at Bocconi, Georgetown, Virginia, West Virginia, Federal Reserve System Committee on Macroeconomics meeting in Philadelphia, my colleagues at the Board of Governors, Paolo Pesenti and Jonathan Willis for comments on earlier versions of the paper, to Shing-Yi Wang for tireless research assistance and to David Bowman for putting up with endless conversations about the paper.
    [Show full text]
  • Gabrielian, E. & Zohary, D
    Eleonora Gabrielian & Daniel Zohary Wild relatives of food crops native to Armenia and Nakhichevan Abstract Gabrielian, E. & Zohary, D.: Wild relatives of food crops native to Armenia and Nakhichevan. — Fl. Medit. 14: 5-80. 2004. — ISSN 1120-4052. The paper surveys the variability, ecology, and distribution of the wild relatives of food crops (cereals, legumes, oil and fiber plants, vegetables, condiments, fruits and nut trees) native to Armenia and Nakhichevan. It focuses on the close wild relatives, i.e., members of the primary wild gene pools (GP-1) of the crops. The wild relatives of about 80 crops were surveyed; and the available information on the distribution (in Armenia and Nakhichevan)) of most of these relatives is also illustrated by 93 site distribution maps. Introduction The aim of this paper is to survey the wild relatives of cultivated food plants that occur in Armenia and Nakhichevan (South Trans-Caucasus). We focus on the close wild rela- tives, which are fully (or almost fully) cross compatible and inter-fertile with their related cultigens, and therefore most attractive to the breeders. In other words, this paper is con- cerned mainly with Armenia’s primary wild gene pools (GP-1) of crops. Some of the more distant wild relatives, which according to Harlan and De Wet (1971) definition belong to the secondary and tertiary wild gene pools (GP-2 and GP-3) of their related crops are sometimes mentioned as well; but usually only in brief. Armenia is a relatively small country. However, it is geo-morphologically and ecologi- cally very varied. More over, it is situated on the cross roads between several phytogeo- graphic regions.
    [Show full text]
  • Chocolate Consumption, Manufacturing and Quality in Western Europe and the United States
    Kingdom – eat on average about ten kilograms of GEOGRAPHY Chocolate chocolate per person every year (Zackowitz, VOLUME 91(3) 2004). Why do Western Europeans consume so PAGES 218-226 much more chocolate on average than Americans? Consumption, Why do Americans and the British have a different understanding of what constitutes quality Manufacturing and chocolate from continental Europeans? We argue that the history of chocolate manufacturing in Europe explains how and why different notions Quality in Western of quality developed. Each innovation in the manufacturing process influenced under- Geography © 2006 standings of quality in the chocolate industry in Europe and the the country in which the innovation was made. These understandings of what constitutes quality chocolate, in turn, influence how chocolate is United States manufactured and marketed in the respective countries. Finally, traditions in marketing and HEIKE C. ALBERTS AND manufacturing shape and are shaped by JULIE L. CIDELL consumer preferences, showing that cultural and economic processes are at work simul- taneously. Our analysis suggests that continental ABSTRACT: In this article we examine why European chocolate manufacturers’ dual focus on chocolate consumption patterns and traditional understandings of quality on the one understandings of quality vary significantly hand, and innovation in terms of flavours on the between the United States and Western Europe other hand, make their chocolate bars so popular. on the one hand, and among western European In both the United States and in Europe, countries on the other hand. We argue that mass-market chocolate makes up the lion’s share different attitudes towards chocolate and of the chocolate market, with gourmet chocolates different marketing strategies by chocolate only accounting for 3.2% in the United States manufacturers explain much of the difference (Hopkins, 2005).
    [Show full text]
  • Drug Enforcement Administration's International Operations
    REDACTED – PUBLIC VERSION THE DRUG ENFORCEMENT ADMINISTRATION’S INTERNATIONAL OPERATIONS U.S. DEPARTMENT OF JUSTICE OFFICE OF THE INSPECTOR GENERAL AUDIT DIVISION AUDIT REPORT 07-19 FEBRUARY 2007 REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION THE DRUG ENFORCEMENT ADMINISTRATION’S INTERNATIONAL OPERATIONS* EXECUTIVE SUMMARY The Drug Enforcement Administration (DEA) is the primary federal agency responsible for investigating illicit drug trafficking organizations operating within the United States. The ultimate goal of the DEA’s efforts is to significantly disrupt drug trafficking operations and to dismantle the criminal organizations entirely, while ultimately bringing their leaders to prosecution, either in the United States or through another country’s judicial system. In order to combat the highest priority drug trafficking organizations, the DEA must extend its operations to other countries where major drug traffickers live and preside over illegal operations. As a result, the DEA has 751 employees in 59 other countries who work with foreign law enforcement agencies, as well as with other U.S. agencies operating in the international arena, to accomplish its mission.1 To support its personnel and operations abroad, in fiscal year (FY) 2006 the DEA had a budget of $312 million for its international operations. The Department of Justice (DOJ), Office of the Inspector General (OIG) conducted this audit of the DEA’s international operations. The objectives of the audit were to: (1) review the DEA’s foreign office performance, including
    [Show full text]
  • Methamphetamine Use Among Thai Women: a Qualitative
    METHAMPHETAMINE USE AMONG THAI WOMEN: A QUALITATIVE STUDY AT THANYARAK INSTITUTE By Sarun Gorsanan A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY Program of Social and Administrative Pharmacy Graduate School SILPAKORN UNIVERSITY 2006 การใชเมทแอมเฟตามีนในสตรีไทย : การวิจัยเชิงคุณภาพในสถาบันธัญญารักษ โดย นายศรัณย กอสนาน วิทยานิพนธน ี้เปนสวนหนงของการศึ่ ึกษาตามหลกสั ูตรปริญญาเภสัชศาสตรดุษฎีบัณฑิต สาขาวิชาเภสชศาสตรั สังคมและการบริหาร บัณฑิตวทยาลิ ัย มหาวิทยาลัยศิลปากร ปการศึกษา 2549 ลิขสิทธิ์ของบณฑั ิตวิทยาลยั มหาวิทยาลยศั ิลปากร The graduate school, Silpakorn University accepted thesis entitled “METHAMPHETAMINE USE AMONG THAI WOMEN: A QUALITATIVE STUDY AT THANYARAK INSTITUTE” by Sarun Gorsanan in partial fulfillment of the requirements for the degree of Doctor of Philosophy, Program of Social and Administrative Pharmacy. …………………………………………….. (Assoc.Prof. Sirichai Chinatankul, Ph.D.) Dean of Graduate School ……….../…………/…………… Thesis advisors 1. Pagamas Maitreemit, Ph.D. 2. Assoc.Prof. Chuthamanee Suthisisang, Ph.D. 3. Assoc.Prof. Luechai Sringernyuang, Ph.D. Thesis committee …………………………….. Chairman …………………………….. Member (Assist. Prof. Burin T. Sriwong, Ph.D.) (Prof. Chomchin Chantaraskul, Ph.D.) ……….../…………/…………… ……….../…………/…………… …………………………….. Member …………………………….. Member (Pagamas Maitreemit, Ph.D.) (Assoc.Prof. Chuthamanee Suthisisang, Ph.D.) ……….../…………/…………… ……….../…………/…………… …………………………….. Member (Assoc.Prof. Luechai Sringernyuang, Ph.D.) ……….../…………/…………… 45354901: MAJOR: SOCIAL AND ADMINISTRATIVE
    [Show full text]